BioSpace News Archive

Drug Development

Kymera Therapeutics Presents Interim Results from STAT3 Degrader Phase 1 Clinical Trial at American Society of Hematology Annual Meeting

Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation, shared new data from its ongoing KT-333 Phase 1 trial.

December 10, 2023
·
8 min read
Biotech Bay

Bristol Myers Squibb Presents New Data at ASH 2023 Demonstrating Clinical Benefit Across B-cell Malignancies with Breyanzi as a Second-Line Treatment in High-Risk Follicular Lymphoma and in Relapsed or Refractory Chronic Lymphocytic Leukemia

Bristol Myers Squibb announced the first disclosure of primary analysis results from the high-risk, second-line cohort of TRANSCEND FL, an open-label, global, multicenter, Phase 2, single-arm study evaluating Breyanzi® in patients with relapsed or refractory follicular lymphoma .

December 10, 2023
·
24 min read
MGI Expands Presence in Latin America with New Partnerships with Genos Médica and TCL Group

MGI Tech Co. Ltd., a company committed to building core tools and technology to lead life science, announced partnerships with Genos Médica, a Mexico-based specialized center in genomics, and TCL Group, a company dedicated to the import and sales of laboratory equipment and supplies in Chile, respectively.

December 10, 2023
·
5 min read